Amcor – Shorts Will Need To Cover

Shares of Amcor are poised to rally as the Bemis takeover deal is finalised.

Hedge funds who are short Amcor & long Bemis will begin unwinding the trade, which will add to the AMC buy-side demand.

We recommend accumulating Amcor at current levels.

In the local entertainment sector, Crown faced heavy selling last week following soft earnings numbers. With the stock now trading at $12.00, we believe value is now being presented.

Crown

 

Wesfarmers – Value Now Emerging

Our Algo Engine generated a buy signal in Wesfarmers following the price retracement from $51 back down to $46.

This “higher low” pattern is referenced to the intraday low of $43.70 posted on May 10th.

WES has been on our watch list with a target entry range of $45 – $46.

We now recommend accumulating the stock, with a view towards selling covered call options to enhance yield.

Wesfarmers

Downer EDI Boasts 13% Earnings Growth

Downer EDI re-affirmed 13% EPS earnings growth, which looks attractive against an average market growth rate of  5 – 7 %.

Macro conditions remain positive in DOW’s key markets across education, health, mining road & rail transport. 

Based on FY20 EPS growth we now have DOW on a forward yield of 4.4%.

Internal momentum indicators are pointing higher and we see scope for an upside move into the $7.80/90 range.

Downer EDI

Star & Crown – Trading Update

Crown’s trading update was weaker than expected as main gaming floor revenue was down 0.6%.

Non-gaming revenue growth was 3.5%, while VIP turnover growth was up 13%.

Star Entertainment showed domestic revenue growth of +6.7% but VIP growth disappointed with it coming in flat on the prior period.

Crown looks like good “value” at $12 and is supported by a current ALGO Engine buy signal.

Aristocrat (ALL:ASX) is also looking well supported near the $26 range.

 

EVN Is In The Buy Zone

With the USD starting November with a weaker tone, gold rallied almost 1.5% overnight to reach a high of $1239.00

EVN is our preferred ASX100 stock to gain exposure to an ongoing move higher in gold prices.

Our medium-term target is $3.65.

Evolution Mining

Medibank – Offshore Buying Interest

In Monday’s Opportunities in Review webinar, we highlighted MPL as a high conviction buy strategy. Our entry level was $2.75.

The price action this week suggests offshore fund managers have been aggressively buying Medibank.

With a defensive 4.3% yield, the stock is attractive at current levels.

Medibank Private